论文部分内容阅读
背景:对于接受直接经皮冠状动脉介入的患者,当前的治疗标准支持早期输注阿昔单抗,然后置入裸金属支架(BMS)。使用西罗莫司洗脱支架(SES)能否进一步改善临床结局尚未证实。替罗非班大剂量快速注射后再予标准输注是否可作为ST段抬高型心肌梗死患者中替
Background. For patients undergoing direct percutaneous coronary intervention, current treatment standards support early infusion of abciximab followed by a bare metal stent (BMS). Whether further improvement of the clinical outcome with sirolimus-eluting stents (SES) has not been demonstrated. Tirofiban high-dose bolus injection followed by standard infusion can be used as ST segment elevation myocardial infarction in patients with